wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38131563-D32B6A36-E141-4C0A-8882-9DFBF1F83ED6
Q38131563-D32B6A36-E141-4C0A-8882-9DFBF1F83ED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38131563-D32B6A36-E141-4C0A-8882-9DFBF1F83ED6
Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody-drug conjugates.
P2860
Q38131563-D32B6A36-E141-4C0A-8882-9DFBF1F83ED6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38131563-D32B6A36-E141-4C0A-8882-9DFBF1F83ED6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a1288e0fc07216792e4a2c706b01102b39555f9
P2860
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.